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Essential oil was obtained from the dried leaves of Euphorbia hirta, commonly called asthma plant. 
Analysis of the oil was carried out on a combined gas chromatograph-mass spectrometer fitted with an 
HP-5 MS (5% phenylmethyl siloxane) column at a temperature programme of 120°C (5 min) increased at 
5°C/min to 320°C and held for 5 min. The major components identified include 3,7,11,15-tetramethyl-2-
hexadecen-1-ol, 6,10,14-trimethyl-2-pentadecanone, hexadecanal, phytol and n-hexadecanoic acid 
adding up to 61.01%. Minor constituents include 2-butoxyethanol, tetradecane, phthalic acid, butyl 
tetradecyl ester, oleic acid, 13-heptadecyn-1-ol, 2-methyl-1-hexadecanol and 1,2-benzene dicarboxylic 
acid diisooctylester. The possible roles of the components in the treatment of asthma and other 
diseases are discussed. The oil may function as a repellent against Anopheles species and thus useful 
for malaria control. 
 





Herbal medicine is currently in the lime light and is given 
more popularity than ever before as sales figures in some 
countries, for example the USA, have risen beyond the 
expectations of some producers. The reasons for this 
change are complex but clearly are connected with what 
could be described as the ‘greening of medicine’ (Ernst, 
2000). Plants and their extracts continue to provide effec-
tive treatment for diseases of all kinds including asthma. 
Asthma is a chronic inflammatory disorder of the airways. 
Airway inflammation causes various symptoms of asthma 
which are often associated with widespread airflow 
obstruction and also cause an associated increase in 
airway responsiveness to a variety of stimuli (Sugita et 
al., 2003). Asthma causes an attack accompanied by 
wheezing, shortness of breath, chest tightness and coug-
hing. Obstruction is often reversible either spontaneously or 
after treatment with a variety of drugs. Asthma medications 
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medicine to reach the lungs effectively. The cornerstone 
of modern asthma therapy is the regular use of inhaled 
corticosteroids (ICS) (Angus, 2002). Many plants have 
been alleged to have curative properties for asthma. 
Among these plants is Euphorbia hirta (Sonibare and 
Gbile, 2008). It is well known and used by the major 
tribes in Nigeria. In Nigeria the name in Yoruba is Emi-ile. 
The plant E. hirta is commonly called asthma plant be-
cause of its alleged efficacy in East and West Africa in 
the treatment of asthma and various respiratory ailments 
(Odugbemi, 2008; Brown, 1995; Oliver, 1959). The plant 
is used as a diuretic, febrifuge, galactogogue, purgative 
and vermifuge. It is reported as medication for intestinal 
amoebic dysentery (Ogbulie et al., 2007; Stuart, 1979). 
Traditionally, the plant is squeezed in water and the ex-
tract taken orally as a remedy for asthma. The phyto-
chemicals in E. hirta include volatile oil, alkaloids, 
tannins, saponins and steroids (Hashemi et al., 2008). The 
analgesic, antipyretic and anti-inflammatory properties of 
the plant have been reported (Lanhers et al., 1991). The 
ethanolic extracts of the plant have been found to 
demonstrate antibacterial activity and toxicological 
potential   (Ogbulie  et  al., 2007). In  vitro  antifungal  and  
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antibacterial properties as well as ulcer-protective effect 
and hepatoprotective activity of the plant extract in rats 
have also been demonstrated (Somchit et al., 2001; Rao 
et al., 2003; Edwin et al., 2007). 
The purpose of this study is to analyze the essential oil 
of E. hirta by GC-MS and identify any of the components 
that may be useful for the management of asthma. 
 
 
MATERIALS AND METHODS 
 
Collection of samples 
 
Several batches of fresh leaves of E. hirta were purchased from 
Mushin Market in Lagos in July 2007. Identification was carried out 
by Mr. T.K. Odewo of the Forestry Research Institute of Nigeria 
(FRIN), Ibadan, where a sample with voucher number FHI 107760 
was deposited in the Herbarium of the Department of Botany.  
 
 
Hydro-distillation of samples 
 
In a typical experiment, 2.4 kg of the fresh leaves were cut into 
small pieces and air-dried in a dust-free environment giving 620 g 
which was blended to obtain the powder. Batches of 100 g of the 
powder were each added to 3 l water and the essential oil obtained 
by hydro-distillation was collected into hexane. The hexane solution 




GC-MS analysis of oil  
 
Analysis of the oil was carried  out  on  a  combined  gas  chromato- 
graph model HP 6890 and mass spectrometer model 5973 (Agilent 
Technologies Ltd.) fitted with a capillary column HP-5 MS (5% 
phenylmethylsiloxane) 30.0 m x 250 µm x 0.25 µm. Helium was 
used as carrier gas. The column temperature was initially 120°C (5 
min) which was thereafter increased at 5°C/min to 320°C and held 
for 5 min. For MS, electron impact ionization was achieved with 
ionization energy of 70 eV. The essential oil was diluted with 
hexane and 2 µl of the diluted sample was injected automatically in 
splitless mode. Identification of the constituent compounds was by 
the Chem-Office software along with the MS library. 
 
 
RESULTS AND DISCUSSION 
 
The gas chromatogram of the essential oil from the 
leaves of E. hirta is shown in Figure 1 while the thirteen 
constituent compounds with abundance of 1% of total 
and above and their corresponding mass spectra are re-
ported in Table 1. The retention times (RT) are reported in 
minutes. The five major compounds identified in the 
essential oil are 3, 7, 11, 15-tetramethyl-2-hexadecene-1-
ol and its isomer (RT
 14.690, 14.800 and 14.881, 26.46%) 
which are methylated unsaturated long chain fatty acid 
alcohols, 6,10,14-trimethyl-2-pentadecanone, a methy-
lated long chain fatty acid ketone, (RT 14.727, 12.37%), 
phytol which is an isomer of 3,7,11,15-tetramethyl-2-
hexadecene-1-ol (RT 15.942, 8.29%), hexadecanal a long 
chain fatty acid aldehyde, (RT
 14.104, 7.63%) and n-
hexadecanoic acid, a fatty acid, (RT
 15.217, 6.26%). 
These major compounds add up to 61.01% of total con-
stituents. The remaining eight compounds are two aro-
matic   dicarboxylic   acid   esters   namely   phthalic  acid  











1. 7.456 1.13 2- butoxy ethanol 
(replib) Ethanol, 2-butoxy-














2. 12.355 1.01 Tetradecane 
(replib) Tetradecane
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13.907 1.40 2-Methyl 
hexadecanol,  
(mainlib) 1-Hexadecanol, 2-methyl-















6. 14.104 7.63 Hexadecanal 
(replib) Hexadecanal
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Table 1. contd. 
 




















11. 15.217 6.26 Hexadecanoic 
acid 
(mainlib) n-Hexadecanoic acid

















12. 15.313 3.88 Phthalic acid, 
butyl tetradecyl 
ester 
(mainlib) Phthalic acid , butyl tetradecyl ester

















13. 15.444 1.42 Oleic acid 
(mainlib) Oleic Acid
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 15.313, 3.88%), 1,2-benzene 
dicarboxylic acid diisooctyl ester (RT
 18.483; 2.90%), oleic 
acid, an unsaturated fatty acid (RT
 15.444, 1.42%), 2-
methyl hexadecanol, (RT
 13.907, 1.40%), 2,6,10-trimethyl 
tetradecane, a methylated long chain alkane, (RT
 12.940, 
1.24%), 13-heptadecyn-1-ol a long chain fatty acid alco-
hol, (RT
 13.585,1.18%), 2-butoxy ethanol (RT
 7.456, 
1.13%) and tetradecane, a long chain alkane, (RT
 12.355, 
1.01%) all adding up to 14.16% of total constituents. 
It is observed that 3,7,11,15-tetramethyl-1-hexadecene-
1-ol was eluted at retention times 14.690, 14.800 and 
14.881 min suggesting isomeric forms and large abun-
dance. These compounds are synonymous with a mix-
ture of cis and trans phytol which are terpenoids. Thus 
phytol and its isomeric forms add up to 34.8%. Phytol is a 
reactive oxygen species-promoting substance. In an 
extensive study, experiments showed that treatment of 
rats with phytol increased oxidative burst in vivo and 
thereby corrected the effect of the genetic polymorphism 
in arthritis-prone Ncf1DA rats (Hulqvist et al., 2006).  
In the same study phytol treatment was also found to 
decrease the auto immune response and to ameliorate 
both the acute and chronic phases of arthritis. The results 
showed that a single injection of phytol mediated a 
surprisingly long suppression of arthritis. An increase in 
oxidative burst capacity was evident the day after phytol 
injection and persisted for several weeks. It was found 
that subcutaneous administration of phytol resulted in 
best preventive effect compared to intraperitoneally or in-
tranasally (Hulqvist et al., 2006).  
However, the users of E. hirta as a phtomedication for 
the management of asthma adopt oral administration of 
the aqueous extract.  
In the study by Hulqvist et al. (2006), the increase in 
oxidative burst after phytol injection was found not to be 
restricted to one anatomical compartment and was 
observed in the blood, bone marrow, spleen and lymph 
node. It was further stated that thymus could also be 
affected by the treatment. Other effects of phytol docu-
mented in the study are as follows: the increase in 
oxidative burst alters cell distribution, it suppresses 
collagen-induced arthritis and collagen type II auto-
immunity, it inhibits arthritis induced without adjuvant oil 
such as pristine, it decreases arthritis severity in esta-
blished disease, the phytol-induced suppression of 
arthritis is reversible (for example with histamine dihydro-
chloride) and its efficiency is comparable to standard 
treatments (Hulqvist et al., 2006). For example, the 
prevention mediated by phytol was found to be more 
pronounced than that of etanercept and while no 
significant reduction of disease severity was seen after a 
single etanercept administration at a certain stage  of  the  




disease, phytol significantly lowered the disease scoring. 
In comparison with methotrexale, phytol was found to be 
valid as a potential therapeutic agent. Thus phytol 
showed comparable or better therapeutic effects in com-
parison with two of the major drugs currently used for 
rheumatoid arthritis (Hulqvist et al., 2006). Phytol was 
also found to be effective at different stages of the 
arthritis. It was found to give good as well as preventive 
and therapeutic results against arthritis. The results show 
that reactive oxygen species-promoting substances such 
as phytol constitute a promising novel class of pharma-
ceuticals for the treatment of rheumatoid arthritis and 
possibly other chronic inflammatory diseases.  
The results in our study show that phytol and its isomer 
3,7,11,15-tetramethyl-2-hexadecen-1-ol present in E. 
hirta possibly contribute to the therapeutic effect of the 
plant in asthma patients. 
In the study by Hulqvist et al, 2006, it was also reported 
that certain oils with alkane structure such as phytol and 
pristane (2,6,10,14-tetramethyl pentadecane) had an 
oxidative burst-inducing capacity in vitro. However, 
despite structural similarity, pristane induced arthritis 
whereas phytol protected against arthritis (Olofsson et al., 
2003). In an investigation of the structure-function 
relationship using short saturated alkanes, those with 15 
carbons or more such as pristane, induced arthritis where 
as shorter alkanes did not. C11 as well as C12 and C13 
shown to increase oxidative burst activity in vitro were 
potent in reducing arthritis severity when administered 5 
days before arthritis induction. However, C16 did not 
increase oxidative burst and did not protect against art-
hritis. However, the report is silent on C14 alkane. The 2, 
6, 10-trimethyl tetradecane present in the essential oil of 
E. hirta may offer relief against asthma and other inflam-
matory diseases such as rheumatoid arthritis. 
It has been reported that a combination of an antihista-
minic compound with a terpenoid gave a pharmaceutical 
composition which when orally administered to human 
was found useful in the prevention and treatment of 
allergic rhinitis (hay fever), mild asthma and urticaria 
(Tschollar et al., 1998). It is pertinent to note that E. hirta 
is used for the management of hay fever in herbal 
medicine. Thus, if there is an antihistamine in the plant or 
human subject, then in the presence of phytol, the 
combination could relieve asthma. Phytol is produced 
from the hydrolysis of chlorophyll and it forms part of the 
molecules of vitamin E and vitamin K (Finar, 2001). 
Vitamin E administered orally has been found to sup-
press the increase in airway reactivity in guinea pigs 
sensitized to ovalbumin and was found to have mem-
brane-stabilizing action (Deepika et al., 2005). In a study 
involving administration of vitamin K2, minaquinone, to 
some patients, it was found to have clinical effects which 
resulted in significant relief in bronchial asthma (Kimur et 
al., 1975; Kimura et al., 1970). Thus phytol could produce 
some of the effects of vitamins E and K resulting in the 





A compound present in appreciable concentration is 
6,10,14-trimethyl-2-pentadecanone, a C15 aliphatic 
methyl ketone. Some studies had established that long 
chain aliphatic methyl ketones showed repellence to 
arthropods, including blood-sucking insects (Ndungu et 
al., 1995; Blum et al., 1966; Torr et al., 1996; Barton, 
2003; Roe, 2004; Gikonyo et al., 2002). In a study on the 
efficacy of aliphatic methyl ketones against Anopheles 
gambiae, a malaria vector, it was found that C7-C10 
compounds had lower activity than those of C11-C15 
indicating the significance of chain length on activity. It 
was also found that in the C11-C15 compounds, odd-car-
bon compounds including 2-pentadecanone were more 
effective than even-carbon compounds especially at high 
concentrations. The C15 compound compared favourably 
with N,N-diethyl-m-toluamide (DEET) a repellent to va-
rious insects including mosquitoes at 10% concentration 
(w/v) (Innocent, et al., 2008). Thus the essential oil from 
E. hirta could be effective repellent against Anopheles 
species because of the presence of 6,10,14 -trimethyl-2-
pentadecanone and would therefore be effective in 
malaria control. 
Many fatty acids are known to have antibacterial and 
antifungal properties (Russel, 1991). Hexadecanoic acid 
and oleic acids are known to have potential antibacterial 
and antifungal activity (McGraw et al, 2002; Seidel and 
Taylor, 2004; Dilika et al., 2000). Oleic acid in concen-
trations as low as 0.7% (v/v) has been found to be 
fungistatic against a wide spectrum of moulds and yeasts 
(Sheba et al., 1999). Free fatty acids including long chain 
C16-C20 unsaturated fatty acids were suggested to be 
responsible for the anti-inflammatory activity in the extract 
from Tinospora smilacina Berth (Li et al., 2004). Thus 
oleic acid and hexadecanoic acid can be of therapeutic 
value when infections are present in asthma patients. 
The anti-inflammatory activity of oleic acid is relevant in 
the management of asthma. The antibacterial, antifungal 
and anti-inflammatory activity identified is relevant in the 
use of the plant for use as anthelmintic and for the mana-
gement of conjunctivitis and dysentery.  
Unsaturated monoglyceride alcohols of chain length of 
16 or 18 carbons were found to be extremely potent in-
activators of some envelope viruses (Sands et al., 1979). 
Thus, the constituent 13-heptadecyn-1-ol, a long chain 
fatty acid alcohol in the essential oil, can be expected to 
exhibit viricidal activity.  
1,2-Benzene dicarboxylic acid diisooctyl ester also 
known as diisooctyl phthalate (DIOP) constitutes 3% of 
the oil. In a report on Human Health Hazard Assessment 
on DIOP, the bulk of labeled phthalates ingested by 
humans were eliminated in urine within the first 24 hours 
and there was no significant tissue accumulation of DIOP 
(NICNAS, 2008). This constituent may therefore not be 
injurious to health. 
Butyl, tetradecyl phthalate ester is present in the oil. 
Phthalic acid esters (PAE) are plasticizers and di-n-butyl 





1971). Thus the butyl tetradecyl phthalate ester in the 
essential oil may enhance its insect repellent activity in 
addition to the 6,10,14-trimethyl-2-pentade-canone pre-
sent in the oil. The toxic effect of phthalate esters is of 
interest. The toxicity of di-n-butyl phthalate to fish has 
been found to be relatively low (Mayer and Sanders, 
1973). However, PAE were found to accumulate in 
invertebrates to a similar degree as found with the same 
species of invertebrates exposed to organochlorine in-
secticides (Johnson et al., 1971). The phthalate was 
rapidly excreted. The percentage of butyl tetradecyl 
phthalate in the essential oil is low at about 4%. The PAE 
are not likely to have been synthesized in the plant but 
may be a contaminant from packaging materials. 
2-Butoxy ethanol is synthetic glycol ether and is 
probably not synthesized by the plant but a contaminant. 
It is present in very low concentration, 1%, in the essen-
tial oil. Although it is readily absorbed following inhalation, 
oral and dermal exposure, it is metabolized by the body. 
The principal effect exerted by 2-butoxy ethanol and its 
metabolite is haematotoxicity and while rat is the most 
sensitive species, human red blood cells are not as 
sensitive (WHO, 1998). 
The constituents, 1,2-benzene dicarboxylic acid diiso-
octyl ester, butyl tetradecyl phthalate esters and 2-butoxy 
ethanol are undesirable constituents of the essential oil 
and they should be removed from it to make it safe for 





Phytol and its isomer, 3,7,11,15-tetramethyl-2-hexa-
decene-1-ol as well as 2,6,10-trimethyl tetradecane 
present in the essential oil from the leaves of E. hirta 
have been shown by Hulqvist et al. (2006) to be relevant 
in the management of inflammatory conditions; hence 
this may be the compound that give relief to patients 
suffering from asthma which is a chronic inflammatory 
disorder of the airways. Oleic acid present in the oil also 
has anti-inflammatory activity (Li et al., 2004) which could 
also produce therapeutic effects in asthma patients. 
Hexadecanoic acid and oleic acid present in the essential 
oil have potential anti bacterial and anti fungal activity 
(McGraw et al., 2002; Seidel and Taylor, 2004; Dilika et 
al., 2000; Sheba et al., 1999). 13-Heptadecyn-1-ol, a long 
chain fatty acid alcohol in the essential oil is a potential 
antiviral agent (Sands et al., 1979). The oil has the 
potential to function as a repellent against Anopheles 
mosquito species because of the presence of 6,10,14-
trimethyl-2-pentadecanone in appreciable quantity and 
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